PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.08%
Revenue growth at 50-75% of AVGO's 12.94%. Martin Whitman would worry about competitiveness or product relevance.
12.14%
Gross profit growth at 50-75% of AVGO's 20.10%. Martin Whitman would question if cost structure or brand is lagging.
15.73%
EBIT growth below 50% of AVGO's 38.46%. Michael Burry would suspect deeper competitive or cost structure issues.
16.53%
Operating income growth under 50% of AVGO's 38.46%. Michael Burry would be concerned about deeper cost or sales issues.
16.87%
Net income growth under 50% of AVGO's 136.84%. Michael Burry would suspect the firm is falling well behind a key competitor.
18.87%
EPS growth under 50% of AVGO's 137.50%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
19.23%
Diluted EPS growth under 50% of AVGO's 131.25%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-2.03%
Share reduction while AVGO is at 0.85%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-2.01%
Reduced diluted shares while AVGO is at 0.82%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.70%
Dividend growth of 0.70% while AVGO is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-20.85%
Negative OCF growth while AVGO is at 180.49%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-43.18%
Negative FCF growth while AVGO is at 203.13%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
74.35%
10Y revenue/share CAGR above 1.5x AVGO's 42.48%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
45.91%
5Y revenue/share CAGR similar to AVGO's 42.48%. Walter Schloss might see both companies benefiting from the same mid-term trends.
21.46%
3Y revenue/share CAGR at 50-75% of AVGO's 42.48%. Martin Whitman would question if the firm lags behind competitor innovations.
24.50%
10Y OCF/share CAGR under 50% of AVGO's 56.67%. Michael Burry would worry about a persistent underperformance in cash creation.
-8.14%
Negative 5Y OCF/share CAGR while AVGO is at 56.67%. Joel Greenblatt would question the firm’s operational model or cost structure.
-25.55%
Negative 3Y OCF/share CAGR while AVGO stands at 56.67%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-15.87%
Negative 10Y net income/share CAGR while AVGO is at 361.05%. Joel Greenblatt sees a major red flag in long-term profit erosion.
65.53%
Below 50% of AVGO's 361.05%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
49.96%
Below 50% of AVGO's 361.05%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
9.16%
Below 50% of AVGO's 42.35%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
15.04%
Below 50% of AVGO's 42.35%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
0.96%
Below 50% of AVGO's 42.35%. Michael Burry suspects a serious short-term disadvantage in building book value.
513.01%
Dividend/share CAGR of 513.01% while AVGO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
384.68%
Dividend/share CAGR of 384.68% while AVGO is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
52.06%
3Y dividend/share CAGR of 52.06% while AVGO is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
12.39%
AR growth well above AVGO's 22.66%. Michael Burry fears inflated revenue or higher default risk in the near future.
5.72%
Inventory growth well above AVGO's 7.23%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-1.67%
Negative asset growth while AVGO invests at 9.19%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
1.55%
Under 50% of AVGO's 9.47%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
5.95%
R&D growth drastically higher vs. AVGO's 9.38%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
5.29%
SG&A growth well above AVGO's 4.35%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.